Skip to main content
Clinical Trials/NCT01732042
NCT01732042CompletedNot Applicable

Retinal Venous Pressure (RVP) in Normals

University Hospital, Basel, Switzerland1 site in 1 country200 target enrollmentStarted: November 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Locations
1
Primary Endpoint
Retinal venous pressure

Study Overview

Brief Summary

Determinate the standard values of the retinal venous pressure in a cohort of healthy subjects.

Detailed Description

The retinal venous pressure (RVP) is an increasingly important dimension in the clinical assessment of retinal blood flow.

In literature only very few and also divergent data on the retinal venous pressure in healthy volunteers are described. A normal value study will provide us with an up-to-date database.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • eye diseases
  • systemic diseases
  • term medication (except contraceptives)
  • pregnancy
  • allergies to the ingredients Alcaine, Tropicamide and Phenylephrine

Outcomes

Primary Outcomes

Retinal venous pressure

Time Frame: 1 hour

Quantification of the retinal venous pressure as a standard value in a cohort of healthy volunteers

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Basel, Switzerland
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials